Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Rewind Therapeutics logo — Pioneering novel treatments for neurological diseases, advan...

Rewind Therapeutics

Pioneering novel treatments for neurological diseases, advancing the way to effective remyelination for multiple sclerosis and myelin-related conditions.

Founded 2017 2-10 employees Series A Total: $18.10M Biotechnology, Health and Wellness

General Information

Company Name Rewind Therapeutics
Founded Year 2017
Employees 2-10
Industries Biotechnology, Health and Wellness
Funding Stage Series A
Social

Get notified when Rewind Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Rewind Therapeutics

Rewind Therapeutics is a biotechnology startup founded in 2017, dedicated to pioneering novel treatments for neurological diseases. The company's innovative approach focuses on advancing the way to effective remyelination for multiple sclerosis and myelin-related conditions. By employing first-in-class remyelinating therapeutics, Rewind Therapeutics inhibits signals that restrict the expansion and migration of oligodendrocyte stem cells, thus promoting effective remyelination. This breakthrough technology offers a promising avenue for medical practitioners to more efficiently treat patients suffering from multiple sclerosis and other myelin-related diseases. The company's recent Series A investment at 25 January 2023 drew attention from a diverse group of investors including Sunstone Capital, MERL Ventures Fund, PMV, Gemma Frisius Fund, Centre for Drug Design & Discovery (CD3), Boehringer Ingelheim Venture Fund. With its focus on disrupting the biotechnology and health and wellness industries, Rewind Therapeutics shows significant potential for addressing critical unmet medical needs.

Taxonomy: Neurological diseases, Remyelination, Therapeutics, Oligodendrocyte stem cells, Multiple sclerosis, Myelin-related conditions, Biotech, Innovative therapies, Medical advancements, Treatment development

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 6
Investor Investor Investor
•••• •••• 		25 Jan 2023
Grant •••••• 1 •••• •••• 01 Aug 2019
Series A •••••• 3
Investor
•••• •••• 		04 Jan 2018

Rewind Therapeutics Alternatives & Competitors

Rewind Therapeutics vs
PTM Therapeutics
PTM Therapeutics United States

Targeting Post Translational Modifications for Therapeutics Development

Series Unknown
2 employees
Health Care, Health and Wellness
Rewind Therapeutics vs
Dorian Therapeutics
Dorian Therapeutics United States

Younger, for longer.

Seed
7 employees
Health Care
Rewind Therapeutics vs
Gismo Therapeutics Inc.
Gismo Therapeutics Inc.

Pioneering advanced treatments for Alzheimer’s and Parkinson’s diseases since 2013.

Grant
6 employees
Biotechnology, Health Care

FAQ About Rewind Therapeutics

Pioneering novel treatments for neurological diseases, advancing the way to effective remyelination for multiple sclerosis and myelin-related conditions.
Rewind Therapeutics was founded in 2017.
Rewind Therapeutics operates in the following industries: Biotechnology, Health and Wellness.
Rewind Therapeutics has approximately 2-10 employees.
Rewind Therapeutics has completed 3 funding rounds, raising a total of $18.10M. The latest funding stage is Series A.
Top alternatives and competitors to Rewind Therapeutics include PTM Therapeutics, Dorian Therapeutics, Gismo Therapeutics Inc., EyeCyte, Progressive Therapeutics Inc (PTI). These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Rewind Therapeutics and PTM Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Rewind Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy